9 (1.3–4.7) vs. 6.2 (5.4–8.3)%, P < 0.001]. During click here a mean follow-up of 42 months, primary outcome was observed in 26 patients (18.2%). When patients were dichotomized by the median value of FMD (2.9%), incidence rates of primary outcome were significantly higher in the group with lower FMD compared to higher FMD (7.2 vs. 3.1 per 100 person-years, P = 0.03). In multivariate Cox analysis, low FMD (≤2.9%) was a significant independent predictor of fatal or nonfatal cardiovascular events (hazard ratio = 2.74, 95% confidence interval: 1.03–7.23, P = 0.04). Furthermore, multivariate fractional

polynomial analysis showed that the risk of primary outcome decreased steadily with higher FMD values. Conclusion: Impaired brachial FMD was a significant independent predictor of fatal or nonfatal cardiovascular

events in PD patients, suggesting that brachial FMD could be useful for stratifying cardiovascular risk in PD patients. MATSUMOTO MAYUMI, HAMADA CHIEKO, AOKI TATSUYA, NAKATA JUNICHIRO, IO HIROAKI, KANEKO KAYO, TOMINO YASUHIKO Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine Introduction: PD, an established Tofacitinib renal replacement therapy in the world, indicates the advantages for preservation of residual renal

function (RRF) and hemodynamic status. However, loss of RRF often induces overhydration Pazopanib price and impaired uremia management. Recently, anuric PD patients receive concomitant hemodialysis (HD) weekly (hybrid PD therapy) in order to improve an inadequate dialysis. We determined the clinical impacts of the hybrid PD therapy in anuric PD patients in short-term observation. Methods: Twelve anuric PD patients were participated in this study. Individual HD session was undergone for 4-hours once a week. Mean age and PD duration at the hybrid PD therapy starting were 49.8 ± 15.5 years and 46.9 ± 15.8 months respectively. Physical findings including echocardiogram and blood biochemical findings were examined at the starting and after6 months. Blood samples were obtained at the starting of HD session. Results: Body weight, cardiothoracic ratio, left ventricular mass index and systolic blood pressure were decreased after 6 months. Hemoglobin was significantly increased after 6 months. Serum levels of urea nitrogen and creatinine after 6 months were comparable with those at the starting. Conclusion: It appears that hybrid PD therapy may play an important role in the improving physiological condition in anuric PD patients.